BIGG

Guidelines for treatment of drug-susceptible tuberculosis and patient care: 2017 update

World Health Organization.

The present guideline update aims to use the best available evidence on the treatment of drug-susceptible TB, as well as on interventions to ensure adequate patient care and support, in order to inform policy decisions made in these technical areas by national TB control programme managers, national poli...

Tuberculose/traitement médicamenteux, Tuberculose multirésistante/traitement médicamenteux, Antituberculeux/administration et posologie, Protocoles cliniques, Résultat thérapeutique, Fluoroquinolones/administration et posologie, Rifampicine/administration et posologie, Isoniazide/administration et posologie, Pyrazinamide/administration et posologie, Éthambutol/administration et posologie

Texte intégral

Rapid advice: treatment of tuberculosis in children

The World Health Organization (WHO) first published guidance for national tuberculosis control programmes on managing tuberculosis in children (hereafter called “the Guidance”) in 2006. The Guidance follows the principles of a public health approach aimed at optimizing outcomes, including the quality...